Atlas Trials

MP0317 in Combination With Chemoimmunotherapy in First Line Treatment for Patients With Advanced Biliary Tract Carcinoma

Clinical trial NCT07036380 · RECRUITING

Trial details

NCT number
NCT07036380
Sponsor
Centre Hospitalier Universitaire de Besancon
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Advanced Biliary Tract Carcinoma
Start date
2025-12-22
Primary completion
2028-11-01
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.